StonvexLoading…
StonvexStonvexStonvexCore line items from INGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $72.40M | $295.30M | $226.73M | $147.64M |
Operating Income | $-9.34M | $-30.21M | $-20.90M | $-13.79M |
Net Income | $-8.32M | $-22.75M | $-15.62M | $-10.33M |
EPS (Diluted) | $-0.30 | $-0.86 | $-0.59 | $-0.40 |
Total Assets | $285.93M | $298.63M | $307.01M | $312.04M |
Total Liabilities | $103.02M | $106.39M | $109.83M | $112.55M |
Cash & Equivalents | $93.11M | $103.73M | $106.48M | $103.69M |
Free Cash Flow OCF − CapEx | $-6.89M | $-13.74M | $-11.82M | $-13.42M |
Shares Outstanding | 27.37M | 27.23M | 27.15M | 27.04M |